Virginie Gressin
Allschwil, BL, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Treatment and management of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross-sectional scientific survey (CLARITY).
Journal: Pulmonary circulation
Published: November 24, 2023
Recognition, diagnosis, and operability assessment of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross-sectional scientific survey (CLARITY).
Journal: Pulmonary circulation
Published: March 03, 2023
Correction: Jansa et al. Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension. J. Clin. Med. 2022, 11, 6189.
Journal: Journal of clinical medicine
Published: February 04, 2023
Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension.
Journal: Journal of clinical medicine
Published: September 02, 2022
Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic.
Journal: Pulmonary circulation
Published: October 15, 2021
Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension.
Journal: The European respiratory journal
Published: September 30, 2019
Health-related quality of life of patients with pulmonary arterial hypertension associated with CHD: the multicentre cross-sectional ACHILLE study.
Journal: Cardiology in the young
Published: March 17, 2016
Controlling the digital ulcerative disease in systemic sclerosis is associated with improved hand function.
Journal: Seminars in arthritis and rheumatism
Published: February 04, 2016
Ischemic digital ulcers affect hand disability and pain in systemic sclerosis.
Journal: The Journal of rheumatology
Published: June 17, 2014
Use of bosentan for digital ulcers related to systemic sclerosis: a real-life retrospective French study of 89 patients treated since specific approval.
Journal: Scandinavian journal of rheumatology
Published: April 12, 2014
Validation of two predictive models for survival in pulmonary arterial hypertension.
Journal: The European respiratory journal
Published: January 06, 2014
Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry.
Journal: International journal of cardiology
Published: March 14, 2013
Last Updated: 09/26/2026